Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,758 | 9 | 79.4% |
| Food and Beverage | $968.02 | 11 | 9.9% |
| Travel and Lodging | $785.46 | 4 | 8.0% |
| Education | $257.10 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,151 | 15 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $2,770 | 2 | $0 (2020) |
| Merz North America, Inc. | $1,450 | 7 | $0 (2019) |
| Allergan, Inc. | $396.85 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $562.50 | 2 | ABBVIE INC. ($562.50) |
| 2023 | $225.00 | 1 | ABBVIE INC. ($225.00) |
| 2022 | $4,363 | 12 | ABBVIE INC. ($4,363) |
| 2021 | $250.00 | 1 | Allergan, Inc. ($250.00) |
| 2020 | $1,950 | 1 | Ipsen Biopharmaceuticals, Inc ($1,950) |
| 2019 | $1,189 | 5 | Ipsen Biopharmaceuticals, Inc ($820.00) |
| 2017 | $1,228 | 4 | MERZ NORTH AMERICA, INC. ($1,082) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $337.50 | General |
| 10/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| 11/22/2023 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $98.28 | General |
| Category: SPASTICITY | ||||||
| 07/28/2022 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2022 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2022 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $68.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $117.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2022 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $397.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $63.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $54.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2022 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $288.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $93.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2021 | Allergan, Inc. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2020 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Neurology | ||||||
| 11/16/2019 | Merz North America, Inc. | XEOMIN (Biological) | Education | Cash or cash equivalent | $85.70 | General |
| Category: MUSCULOSKELETAL | ||||||
| 11/15/2019 | Merz North America, Inc. | XEOMIN (Biological) | Education | Cash or cash equivalent | $171.40 | General |
| Category: MUSCULOSKELETAL | ||||||
| 05/30/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Consulting Fee | Cash or cash equivalent | $820.00 | General |
| Category: Neurology | ||||||
| 01/18/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | In-kind items and services | $79.73 | General |
| Category: MUSCULOSKELETAL | ||||||
| 01/18/2019 | Merz North America, Inc. | XEOMIN (Biological) | Travel and Lodging | In-kind items and services | $32.04 | General |
| Category: MUSCULOSKELETAL | ||||||
| 10/18/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $152.66 | General |
| Category: Musculoskeletal | ||||||
| 10/12/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Musculoskeletal | ||||||
| 10/11/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $128.94 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 164 | 5,159 | $162,643 | $37,852 |
| 2022 | 6 | 141 | 8,249 | $183,896 | $52,852 |
| 2021 | 6 | 175 | 7,310 | $142,365 | $52,123 |
| 2020 | 6 | 190 | 8,689 | $154,322 | $59,183 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 4,900 | $106,860 | $23,986 | 22.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 31 | 53 | $23,413 | $5,778 | 24.7% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2023 | 16 | 33 | $11,228 | $2,559 | 22.8% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2023 | 13 | 31 | $7,000 | $1,617 | 23.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 53 | 97 | $5,919 | $1,522 | 25.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 21 | $4,620 | $1,422 | 30.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 24 | $3,603 | $969.12 | 26.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 19 | 8,000 | $129,620 | $38,968 | 30.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2022 | 22 | 40 | $18,296 | $4,229 | 23.1% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2022 | 15 | 32 | $11,209 | $2,841 | 25.3% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 17 | 42 | $8,974 | $2,585 | 28.8% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2022 | 11 | 31 | $7,161 | $1,890 | 26.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 42 | 89 | $5,621 | $1,427 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 15 | $3,016 | $912.45 | 30.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 17 | 7,010 | $68,347 | $33,223 | 48.6% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 21 | 36 | $15,867 | $4,009 | 25.3% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Facility | 2021 | 24 | 50 | $16,978 | $3,678 | 21.7% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 12 | 25 | $13,391 | $3,674 | 27.4% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2021 | 18 | 39 | $9,287 | $2,922 | 31.5% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2021 | 19 | 40 | $9,028 | $2,052 | 22.7% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 47 | 90 | $5,540 | $1,479 | 26.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 20 | $3,928 | $1,087 | 27.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 22 | 8,400 | $82,320 | $40,153 | 48.8% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2020 | 15 | 32 | $15,785 | $4,433 | 28.1% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2020 | 23 | 53 | $12,730 | $3,952 | 31.0% |
About Ib Odderson
Ib Odderson is a Physical Medicine & Rehabilitation healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194800912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ib Odderson has received a total of $9,768 in payments from pharmaceutical and medical device companies, with $562.50 received in 2024. These payments were reported across 26 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($7,758).
As a Medicare-enrolled provider, Odderson has provided services to 670 Medicare beneficiaries, totaling 29,407 services with total Medicare billing of $202,011. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Bellevue, WA
- Active Since 10/27/2006
- Last Updated 09/06/2012
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1194800912
Products in Payments
- BOTOX (Biological) $4,838
- DYSPORT (Drug) $2,770
- Xeomin (Biological) $1,082
- XEOMIN (Biological) $368.87
- BOTOX NEURO REHAB (Drug) $146.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Bellevue
Matthew Brown
Physical Medicine & Rehabilitation — Payments: $1,065
Dr. Garrett Hyman, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $912.06
Kathleen Burgess, Md, MD
Physical Medicine & Rehabilitation — Payments: $500.00
Wesley Hardgrove, Md, MD
Physical Medicine & Rehabilitation — Payments: $371.99
Dr. Michele Arnold, Md, MD
Physical Medicine & Rehabilitation — Payments: $180.74
Dr. Otono Silva, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $169.69